Skip to main content
EXMceuticals Inc. logo

EXMceuticals Inc. — Investor Relations & Filings

ISIN · CA30207T1049 LEI · 549300Y5RECXIIFSFF71 CSE Manufacturing
Open in API
Filings indexed 219 across all filing types
Latest filing 2022-04-05 Capital/Financing Update
Country CA Canada
Listing CSE

About EXMceuticals Inc.

https://exmceuticals.com/

EXMceuticals Inc. is a pharmaceutical biosciences company focused on the potential health and wellness benefits of hemp and cannabis. The company specializes in the sustainable cultivation, processing, and wholesale of medicinal cannabis. Its core activities involve the extraction and strategic matching of natural bioactive ingredients from the cannabis plant, aiming to supply high-grade, pharmaceutical-grade cannabinoid ingredients globally. EXMceuticals maintains processing operations in Lisbon, Portugal, and holds production licenses in Africa to support the export of therapeutic cannabis products.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a detailed description of a financial product, specifically a structured note or debt instrument linked to semiconductor companies' stock performance. It includes terms such as issuer, issue date, maturity date, underlying assets, coupon payment conditions, redemption clauses, risk factors, and examples of payout scenarios. The document is not a report of financial results, management discussion, or regulatory filing. It is not an announcement of a report but a detailed offering document or prospectus supplement for a financial instrument. This type of document fits best under Capital/Financing Update (CAP), as it provides detailed information about a capital raising instrument and its terms for investors.
2022-04-05 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a short announcement about the sale of a subsidiary by EXMceuticals Inc. It provides details of the transaction (sale of Portugal subsidiary for cash consideration) and mentions seeking alternative business opportunities. There are no financial statements, no detailed financial performance data, no regulatory certifications, or voting results. The document is clearly an announcement of a capital transaction (sale of a subsidiary) which relates to the company's financing or capital structure. Given the content and length (1059 characters), it is not a full report but an update on a financing-related activity. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2022-04-05 English
News release - English.pdf
Regulatory Filings
2022-01-11 English
News release - English.pdf
Regulatory Filings
2021-12-22 English
Notice of the meeting and record date - English.pdf
AGM Information Classification · 90% confidence The document is a notice regarding the upcoming Annual General and Special Meeting of EXMceuticals Inc., including details such as meeting date, record date, and voting information. It does not contain the actual meeting materials or presentations but rather announces the meeting and related administrative details. The document length is short (1100 characters), and it serves as a notification rather than the full AGM materials. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or notices related to it.
2021-10-06 English
Notice of the meeting and record date - English.pdf
Regulatory Filings
2021-08-13 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.